Advent Convertible Bond ETF (NYSEARCA:ACVT) Sees Large Drop in Short Interest

Posted by Amy Steele on Mar 25th, 2026

Advent Convertible Bond ETF (NYSEARCA:ACVT – Get Free Report) was the target of a large drop in short interest in the month of March. As of March 13th, there was short interest totaling 13 shares, a drop of 99.4% from the February 26th total of 2,020 shares. Based on an average daily volume of 8,152 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are short sold. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 8,152 shares, the days-to-cover ratio is presently 0.0 days.

Institutional Investors Weigh In On Advent Convertible Bond ETF

An institutional investor recently bought a new position in Advent Convertible Bond ETF stock. Advent Capital Management DE purchased a new stake in Advent Convertible Bond ETF (NYSEARCA:ACVT – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 990,000 shares of the company’s stock, valued at approximately $25,862,000. Advent Capital Management DE owned approximately 96.12% of Advent Convertible Bond ETF as of its most recent filing with the Securities and Exchange Commission.

Advent Convertible Bond ETF Stock Performance

ACVT stock traded up $0.02 during midday trading on Wednesday, reaching $26.23. 202 shares of the company’s stock traded hands, compared to its average volume of 2,563. The firm’s fifty day moving average price is $26.75 and its 200-day moving average price is $26.81. Advent Convertible Bond ETF has a 52 week low of $25.06 and a 52 week high of $27.19.

About Advent Convertible Bond ETF

(Get Free Report)

The Advent Convertible Bond ETF (ACVT) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund is an actively managed fund comprised of US-issued and USD-denominated foreign-issued convertible securities. The fund seeks to deliver total return through income and capital appreciation. ACVT was launched on Apr 30, 2025 and is issued by Advent.